Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)
Owlet (OWLT) posted quarterly Net Income towards Common Stockholders of -$4.1 million for Q1 2026, down 336.96% year-over-year from $1.7 million in Q1 2025, and up 58.15% quarter-over-quarter from -$9.9 million in Q4 2025.
Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Owlet (OWLT) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 336.96% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$48.6 million (down 179.48% YoY), while the FY2025 annual figure was -$41.9 million, down 143.1% from the prior year.
- Net Income towards Common Stockholders grew to -$4.1 million in Q1 2026 per OWLT's latest filing, from -$9.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.7 million in Q3 2025 and bottomed at -$37.2 million in Q2 2025.
- Historically, Net Income towards Common Stockholders has averaged -$10.7 million across 5 years, with a median of -$9.7 million in 2024.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 139.61% in 2025 and fell as far as 1286.54% in 2025.
- Owlet's Net Income towards Common Stockholders stood at -$19.5 million in 2022, then surged by 57.85% to -$8.2 million in 2023, then slipped by 17.8% to -$9.7 million in 2024, then retreated by 2.23% to -$9.9 million in 2025, then jumped by 58.15% to -$4.1 million in 2026.
- Business Quant data shows OWLT's Net Income towards Common Stockholders at -$4.1 million in Q1 2026, -$9.9 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Owlet | 160.25 Mn | 123.70 Mn | 21.82 Mn | -1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.47 Mn |
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -9.90 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -37.19 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -6.76 Mn |
| Jun 30, 2024 | -2.68 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | -8.22 Mn |
| Sep 30, 2023 | -6.96 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -12.52 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |